文献速递脑血管病外科

大而复杂动静脉畸形分期体积伽玛刀放射外科治疗的结果:闭塞率与不断演变的治疗模式的临床结局

Results of volume-staged fractionated Gamma Knife radiosurgery for large complex arteriovenous malformations: obliteration rates and clinical outcomes of an evolving treatment paradigm.
PubMed 文献 · J Neurosurg · 2016-01-01

该研究前瞻性纳入2004至2012年间20例大而复杂脑动静脉畸形(AVM)患者,采用分期体积伽玛刀放射外科(GKRS)治疗,病灶体积大于10 cm³时启用分期策略。中位AVM体积15.9 cm³,各分期中位边缘剂量20 Gy,分期平均间隔15个月。平均随访45个月后8例(42%)确认闭塞,4例(20%)病灶体积缩小超过75%,无新出血事件发生于急性出血起病患者,1例(5%)发生放射性坏死导致感觉运动偏瘫。

要点

  • 大而复杂AVM分期体积GKRS后平均随访45个月,42%(8例)确认闭塞,20%(4例)体积缩小超过75%。
  • 高病灶血流速率和分期间隔小于11.7个月与AVM闭塞显著相关(p=0.021和p=0.041)。
  • 年龄小于44岁与AVM体积缩小超过75%显著相关(p=0.024),但与闭塞无关。

核心结论

  • 分期体积GKRS是大而复杂脑AVM的有效且安全的治疗策略,尤其对于显微手术或血管内途径可能带来更高风险的患者。
  • 放射剂量可达20 Gy可安全给予,分期间隔应短于11.7个月以增加闭塞机会。

研究设计与样本

  • 前瞻性纳入作者所在AVM数据库2004至2012年间20例大而复杂AVM患者。
  • 病灶体积大于10 cm³时采用分期策略,中位AVM体积15.9 cm³(范围10.1-34.3 cm³),各分期中位边缘剂量20 Gy(范围18-25 Gy),分期平均间隔15个月(±9个月)。

主要发现

  • 平均随访45个月(范围19-87个月)后,8例(42%)确认闭塞,4例(20%)原始病灶体积缩小超过75%。
  • 6例(30%)以出血起病,8例(40%)以癫痫起病;癫痫起病患者中75%达到Engel I-II级(50% Engel I级,25% Engel II级)。
  • 7例治疗后神经功能缺损加重的患者中,71.5%(5/7)报告完全缓解或改善。
  • 急性出血起病患者随访期间无一例再出血;1例(5%)发生放射性坏死导致感觉运动偏瘫;2例(10%)GKRS后出血,其中仅1例(5%)有症状。
  • 高病灶血流速率和分期间隔小于11.7个月与AVM闭塞显著相关(p=0.021和p=0.041);年龄小于44岁与AVM体积缩小超过75%显著相关(p=0.024),但与闭塞无关。

临床怎么用

  • 作者认为,对于显微手术或血管内途径可能带来更高风险的大而复杂脑AVM,分期体积GKRS是有效且安全的治疗策略。
  • 作者指出,放射剂量可达20 Gy可安全给予,分期间隔应短于11.7个月以增加闭塞机会。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE There are few reported series regarding volume-staged Gamma Knife radiosurgery (GKRS) for the treatment of large, complex, cerebral arteriovenous malformations (AVMs). The object of this study was to report the results of using volume-staged Gamma Knife radiosurgery for patients affected by large and complex AVMs. METHODS Data from 20 patients with large AVMs were prospectively included in the authors' AVM database between 2004 and 2012. A staging strategy was used when treating lesion volumes larger than 10 cm3. Hemorrhage and seizures were the presenting clinical feature for 6 (30%) and 8 (40%) patients, respectively. The median AVM volume was 15.9 cm3 (range 10.1-34.3 cm3). The mean interval between stages (± standard deviation) was 15 months (± 9 months). The median margin dose for each stage was 20 Gy (range 18-25 Gy). RESULTS Obliteration was confirmed in 8 (42%) patients after a mean follow-up of 45 months (range 19-87 months). A significant reduction (> 75%) of the original nidal volume was achieved in 4 (20%) patients. Engel Class I-II seizure status was reported by 75% of patients presenting with seizures (50% Engel Class I and 25% Engel Class II) after radiosurgery. After radiosurgery, 71.5% (5/7) of patients who had presented with a worsening neurological deficit reported a complete resolution or amelioration. None of the patients who presented acutely because of hemorrhage experienced a new bleeding episode during follow-up. One (5%) patient developed radionecrosis that caused sensorimotor hemisyndrome. Two (10%) patients sustained a bleeding episode after GKRS, although only 1 (5%) was symptomatic. High nidal flow rate and a time interval between stages of less than 11.7 months were factors significantly associated with AVM obliteration (p = 0.021 and p = 0.041, respectively). Patient age younger than 44 years was significantly associated with a greater than 75% reduction in AVM volume but not with AVM obliteration (p = 0.024). CONCLUSIONS According to the results of this study, volume-staged GKRS is an effective and safe treatment strategy for large, complex, cerebral AVMs for which microsurgery or endovascular approaches could carry substantially higher risks to the patient. Radiation doses up to 20 Gy can be safely administered. The time interval between stages should be shorter than 11.7 months to increase the chance of obliteration. High nidal flow and a patient age younger than 44 years were factors associated with nidus obliteration and significant nidus reduction, respectively.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Franzin A, Panni P, Spatola G, et al. Results of volume-staged fractionated Gamma Knife radiosurgery for large complex arteriovenous malformations: obliteration rates and clinical outcomes of an evolving treatment paradigm. J Neurosurg. 2016. PMID: 27903180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。